205 related articles for article (PubMed ID: 16011590)
21. HLA-dependent hypersensitivity to nevirapine in Sardinian HIV patients.
Littera R; Carcassi C; Masala A; Piano P; Serra P; Ortu F; Corso N; Casula B; La Nasa G; Contu L; Manconi PE
AIDS; 2006 Aug; 20(12):1621-6. PubMed ID: 16868443
[TBL] [Abstract][Full Text] [Related]
22. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L;
Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778
[TBL] [Abstract][Full Text] [Related]
23. The effect of stromal cell-derived factor 1 (SDF1/CXCL12) genetic polymorphism on HIV-1 disease progression.
Reiche EM; Ehara Watanabe MA; Bonametti AM; Kaminami Morimoto H; Akira Morimoto A; Wiechmann SL; Breganó JW; Matsuo T; Vissoci Reiche F; Miranda HC; Brajão Oliveira K; Vogler IH; Siscar AR
Int J Mol Med; 2006 Oct; 18(4):785-93. PubMed ID: 16964435
[TBL] [Abstract][Full Text] [Related]
24. Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression.
Daar ES; Lynn HS; Donfield SM; Lail A; O'Brien SJ; Huang W; Winkler CA;
J Infect Dis; 2005 Nov; 192(9):1597-605. PubMed ID: 16206074
[TBL] [Abstract][Full Text] [Related]
25. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
[TBL] [Abstract][Full Text] [Related]
26. Progression to AIDS in French haemophiliacs: association with HLA-B35.
Sahmoud T; Laurian Y; Gazengel C; Sultan Y; Gautreau C; Costagliola D
AIDS; 1993 Apr; 7(4):497-500. PubMed ID: 8507416
[TBL] [Abstract][Full Text] [Related]
27. HLA markers and progression in psoriatic arthritis.
Gladman DD; Farewell VT; Kopciuk KA; Cook RJ
J Rheumatol; 1998 Apr; 25(4):730-3. PubMed ID: 9558177
[TBL] [Abstract][Full Text] [Related]
28. Protective effects of IL4-589T and RANTES-28G on HIV-1 disease progression in infected Thai females.
Wichukchinda N; Nakayama EE; Rojanawiwat A; Pathipvanich P; Auwanit W; Vongsheree S; Ariyoshi K; Sawanpanyalert P; Shioda T
AIDS; 2006 Jan; 20(2):189-96. PubMed ID: 16511411
[TBL] [Abstract][Full Text] [Related]
29. The V118I mutation as a marker of advanced HIV infection and disease progression.
Zaccarelli M; Tozzi V; Lorenzini P; Forbici F; Narciso P; Ceccherini-Silberstein F; Trotta MP; Bertoli A; Liuzzi G; Marconi P; Mosti S; Perno CF; Antinori A
Antivir Ther; 2007; 12(2):163-8. PubMed ID: 17503658
[TBL] [Abstract][Full Text] [Related]
30. Association between Nef-specific CD8 T-cell responses and disease progression in HIV-1 subtype B infection.
Jiao Y; Li TS; Xie J; Han Y; Qiu ZF; Zuo LY; Mourez T; Wang AX
Chin Med J (Engl); 2006 Oct; 119(19):1609-15. PubMed ID: 17042973
[TBL] [Abstract][Full Text] [Related]
31. Mortality and morbidity among HIV type-1-infected patients during the first 5 years of a multicountry HIV workplace programme in Africa.
Van der Borght SF; Clevenbergh P; Rijckborst H; Nsalou P; Onyia N; Lange JM; de Wit TF; Van der Loeff MF
Antivir Ther; 2009; 14(1):63-74. PubMed ID: 19320238
[TBL] [Abstract][Full Text] [Related]
32. Nef alleles from children with non-progressive HIV-1 infection modulate MHC-II expression more efficiently than those from rapid progressors.
Schindler M; Wildum S; Casartelli N; Doria M; Kirchhoff F
AIDS; 2007 May; 21(9):1103-7. PubMed ID: 17502720
[TBL] [Abstract][Full Text] [Related]
33. Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population.
Reiche EM; Bonametti AM; Morimoto HK; Morimoto AA; Wiechemann SL; Matsuo T; Vissoci Reiche F; Vogler IH
Int J Mol Med; 2008 Mar; 21(3):387-95. PubMed ID: 18288387
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C at the israeli national hemophilia center.
Maor Y; Bashari D; Kenet G; Lalezari S; Lubetsky A; Luboshitz J; Schapiro JM; Avidan B; Bar-Meir S; Martinowitz U
Haemophilia; 2006 Jan; 12(1):68-74. PubMed ID: 16409178
[TBL] [Abstract][Full Text] [Related]
35. High versus ultra-high purity factor VIII concentrate therapy: prospective evaluation of immunological and clinical parameters in HIV seronegative and seropositive hemophiliacs.
Varon D; Schulman S; Dardik R; Barzilai A; Bashari D; Martinowitz U
Thromb Haemost; 1994 Sep; 72(3):359-62. PubMed ID: 7855784
[TBL] [Abstract][Full Text] [Related]
36. Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy.
Huttner AC; Kaufmann GR; Battegay M; Weber R; Opravil M
AIDS; 2007 May; 21(8):939-46. PubMed ID: 17457087
[TBL] [Abstract][Full Text] [Related]
37. [Distribution of transplantation HLA antigens in children and adolescents with meningitis of various etiology].
Feĭzullaeva NA
Probl Tuberk; 1999; (2):43-4. PubMed ID: 10420751
[TBL] [Abstract][Full Text] [Related]
38. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
[TBL] [Abstract][Full Text] [Related]
39. Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.
Teixeira SL; Bastos FI; Hacker MA; Morgado MG
Infect Genet Evol; 2009 Jul; 9(4):638-42. PubMed ID: 19460331
[TBL] [Abstract][Full Text] [Related]
40. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
